NEW YORK, July 17, 2017 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against DryShips, Inc. (“DryShips” or the “Company”) (NASDAQ:DRYS) in the United States District Court for the Southern District of New York on behalf of a class consisting of investors who purchased or otherwise acquired DryShips securities on the open market from June 8, 2016 through July 12, 2017, inclusive (the “Class Period”), seeking to recover compensable damages caused by Defendants’ violations of the Securities Exchange Act of 1934.
The Complaint alleges that (1) Defendants engaged in a systemic stock-manipulation scheme to artificially inflate DryShips’ share price; (2) DryShips’ transactions with Kalani Investments Ltd. (“Kalani”), a British Virgin Islands firm, were an illegal capital-raising scheme, due in part to Kalani’s failure to register as an underwriter with the SEC; and (3) as a result, DryShips’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
If you wish to serve as lead plaintiff, you must move the Court no later than September 11, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 



